The first comprehensive, fully integrated CRO devoted to oncology and rare disease

You develop compounds that change lives. Precision’s uniquely integrated offering enables the science of precision medicine by combining novel clinical trial designs, industry-leading operational and medical experts, advanced biomarker solutions, and an unequivocal passion for rare diseases and oncology. The result: a tailored pathway to approval for oncology and rare disease innovators.

Headquartered in both the US and Europe, we have the capability and capacity to conduct and support your clinical trials around the globe.

We are driven by the promise of precision medicine

Cancer and rare diseases can be devastating—creating heavy burdens for both patients and those who love them. At Precision, we are passionate about accelerating the pathway for oncology and rare disease drug development to speed novel therapeutics to people whose lives depend on them. This has been our mission from our inception, and we focus on precision medicine because we believe it is the most effective route to success. Our employees share this commitment. It takes passion to eliminate a potential killer. We’ve got it.
Precision by the numbers

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics, adaptive clinical trial execution to regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.